About Atomwise
Atomwise operates in the pharmaceutical industry by using artificial intelligence (AI) to enhance drug discovery. The main product is an AI engine that employs machine learning and convolutional neural networks to analyze extensive chemical libraries. This technology allows Atomwise to identify new small molecule medicines more efficiently than traditional methods. The company primarily serves clients in the healthcare and pharmaceutical sectors, aiming to streamline the drug discovery process. Atomwise's business model involves developing and co-developing drug candidates, which are then sold to pharmaceutical companies or healthcare providers. What sets Atomwise apart from its competitors is its integration of AI and machine learning, which accelerates the creation of effective medicines while reducing costs and time. The ultimate goal of Atomwise is to improve patient outcomes by delivering better treatments more quickly.